Q32 Bio Inc. Deferred Income Tax Expense (Benefit)
Q32 Bio Inc. (FIXX) reported Deferred Income Tax Expense (Benefit) of $100.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2025-03-11
- Q32 Bio Inc. deferred income tax expense (benefit) for fiscal 2024 was $100.00K, a 66.67% decline from fiscal 2023.
- Q32 Bio Inc. deferred income tax expense (benefit) for fiscal 2023 was $300.00K.
| Period end | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|
| 2024-12-31 | $100.00K 10-K · filed 2025-03-11 |
| 2023-12-31 | $300.00K 10-K · filed 2025-03-11 |